NCT02166463
Clinical Trial Information
Trial Number: NCT02166463 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Lymphoma - Hodgkin Lymphoma
Trial Title:
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Study ID:
AHOD1331
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®